Suk Seo is a Gastroenterology physician affiliated with Kaiser Permanente. OpenAlex indexes 27 publications with 455 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
200 Med Plaza
Suite 365, 214
Los Angeles, CA 900950001
Telephone
310-301-8708Provider last certified this registry record 12 Jan 2022.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
79.6%Osmotic Laxative23.3%Gavilyte-C76%Lactulose24%Part D<11 patientsProton pump inhibitor17.2%Omeprazole56%Pantoprazole Sodium44%Part D≥24 patients+ 7 more classes in this area
Cardiovascular
6.1%Bile Acid Sequestrant6.1%Cholestyramine100%Part D<11 patientsAnti-infectives
5.4%Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor3%Entecavir100%Part D<11 patientsNucleoside and nucleotide reverse transcriptase inhibitors2.4%Vemlidy100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Chronic Hepatitis B Identification and Surveillance Program Improves Care in an Integrated Health Plan
The American Journal of Gastroenterology
2024 - S1823 Comparative Analysis of Clinical Outcomes in Hepatitis B/Delta Virus Co-infection vs Hepatitis B Mono-Infection in a Large Integrated Healthcare System
The American Journal of Gastroenterology
2024 - Cancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals
Cancer Epidemiology Biomarkers & Prevention
2021 - Prevalence of Spontaneous Clearance of Hepatitis C Virus Infection Doubled From 1998 to 2017
Clinical Gastroenterology and Hepatology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Louis Fehrenbacher, MD
Kaiser Permanente
Susy Peng, MD
Kaiser Permanente
Prasanth Manthena, MD
Kaiser Permanente
Alan Go, MD
Kaiser Permanente
Charles Rice, MD
The Rockefeller University
Edward Loftus, MD
Mayo Clinic Rochester
Naga Chalasani, MD
Indiana University School of Medicine
Bruce Sands, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”